Getein Biotech, Inc
SSE:603387.SS
8.24 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,164.799 | 1,369.162 | 1,821.861 | 1,401.701 | 1,123.336 | 968.204 | 686.238 | 488.583 | 369.09 | 276.42 | 210.293 | 154.195 | 73.64 |
| Cost of Revenue
| 358.424 | 465.311 | 636.392 | 482.461 | 415.297 | 263.414 | 144.769 | 87.334 | 69.353 | 47.506 | 34.012 | 25.586 | 10.292 |
| Gross Profit
| 806.375 | 903.851 | 1,185.468 | 919.24 | 708.039 | 704.791 | 541.469 | 401.249 | 299.737 | 228.914 | 176.282 | 128.61 | 63.349 |
| Gross Profit Ratio
| 0.692 | 0.66 | 0.651 | 0.656 | 0.63 | 0.728 | 0.789 | 0.821 | 0.812 | 0.828 | 0.838 | 0.834 | 0.86 |
| Reseach & Development Expenses
| 181.207 | 217.992 | 223.222 | 163.393 | 119.068 | 104.731 | 80.595 | 54.041 | 39.283 | 31.919 | 30.001 | 14.001 | 7.948 |
| General & Administrative Expenses
| 27.277 | 27.562 | 34.854 | 29.968 | 25.951 | 25.013 | 20.395 | 13.738 | 9.759 | 14.112 | 17.605 | 27.862 | 15.516 |
| Selling & Marketing Expenses
| 119.971 | 347.441 | 303.325 | 233.51 | 182.735 | 174.103 | 152.051 | 101.845 | 74.781 | 51.689 | 35 | 28.943 | 24.623 |
| SG&A
| 147.248 | 375.004 | 338.179 | 263.478 | 208.687 | 199.116 | 172.446 | 115.583 | 84.54 | 65.801 | 52.605 | 56.806 | 40.139 |
| Other Expenses
| 219.868 | 0 | 69.018 | 56.04 | 33.002 | 22.788 | 4.478 | 0.858 | 9.116 | 11.129 | 8.107 | 6.283 | 3.416 |
| Operating Expenses
| 548.323 | 616.509 | 630.419 | 482.911 | 360.757 | 326.634 | 289.356 | 186.007 | 150.491 | 118.821 | 95.931 | 59.265 | 41.263 |
| Operating Income
| 258.052 | 306.588 | 563.256 | 452.788 | 377.997 | 398.913 | 282.792 | 223.096 | 152.62 | 111.81 | 80.897 | 69.415 | 21.687 |
| Operating Income Ratio
| 0.222 | 0.224 | 0.309 | 0.323 | 0.336 | 0.412 | 0.412 | 0.457 | 0.414 | 0.404 | 0.385 | 0.45 | 0.295 |
| Total Other Income Expenses Net
| -4.62 | -1.646 | -3.997 | -1.155 | 66.547 | -2.769 | 46.558 | 0.624 | 12.959 | 11.129 | 8.074 | 7.246 | 3.446 |
| Income Before Tax
| 253.432 | 304.942 | 559.979 | 451.633 | 374.04 | 395.97 | 287.271 | 223.954 | 161.669 | 122.939 | 88.971 | 75.681 | 25.103 |
| Income Before Tax Ratio
| 0.218 | 0.223 | 0.307 | 0.322 | 0.333 | 0.409 | 0.419 | 0.458 | 0.438 | 0.445 | 0.423 | 0.491 | 0.341 |
| Income Tax Expense
| 23.553 | 20.861 | 56.034 | 39.622 | 43.727 | 46.023 | 36.626 | 30.173 | 23.347 | 18.151 | 14.409 | 10.053 | 3.146 |
| Net Income
| 223.636 | 279.772 | 498.91 | 398.99 | 304.733 | 339.672 | 249.612 | 193.988 | 138.357 | 105.067 | 75.136 | 65.628 | 21.96 |
| Net Income Ratio
| 0.192 | 0.204 | 0.274 | 0.285 | 0.271 | 0.351 | 0.364 | 0.397 | 0.375 | 0.38 | 0.357 | 0.426 | 0.298 |
| EPS
| 0.44 | 0.55 | 0.98 | 0.79 | 0.6 | 0.67 | 0.49 | 0.45 | 0.36 | 0.28 | 0.2 | 0.24 | 0.081 |
| EPS Diluted
| 0.44 | 0.55 | 0.98 | 0.79 | 0.6 | 0.66 | 0.49 | 0.45 | 0.36 | 0.28 | 0.2 | 0.24 | 0.081 |
| EBITDA
| 362.007 | 426.888 | 654.551 | 522.11 | 424.742 | 431.438 | 276.867 | 246.381 | 164.874 | 120.277 | 87.097 | 70.273 | 22.96 |
| EBITDA Ratio
| 0.311 | 0.312 | 0.359 | 0.372 | 0.378 | 0.446 | 0.403 | 0.504 | 0.447 | 0.435 | 0.414 | 0.456 | 0.312 |